RevMedx
RevMedX is a privately held medical device company that designs, develops, and manufactures FDA-cleared expandable minisponge hemorrhage control products (XSTAT, XGAUZE) and CoTCCC-recommended TX Series ratcheting tourniquets for U.S. Military medics, tactical law enforcement, EMS providers, and civilian first responders.
- Company typePrivate
- Founded2013
- HeadquartersWilsonville, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What RevMedx does
RevMedX (legal entity RevMedx, Inc.) is a privately held specialty medical device company headquartered at 25749 SW Canyon Creek Rd Suite 300, Wilsonville, Oregon, that designs, develops, and manufactures hemorrhage control products for prehospital, tactical, and battlefield use. The company's core technology is a proprietary expandable minisponge (cellulose-based) hemostatic platform in which compressed sponges expand up to 10x upon contact with blood to fill wound cavities and apply internal hemostatic pressure without manual compression. This platform underpins the FDA-cleared XSTAT P30 ($299 per pack) and XSTAT P15 ($92 per pack) injectable devices — indicated respectively for severe junctional bleeding (axilla/groin) and narrow-entrance extremity wounds — and the over-the-counter XGAUZE Trauma Pad ($79). RevMedX also sells the CoTCCC-recommended TX Series ratcheting tourniquets (TX2 at $39.95, TX3 at $35, TX-XL at $43.50) and the AirWrap compression bandage and SharkBite Blast Injury Kit sub-brands.
The company monetizes through a hybrid go-to-market: a Shopify-powered direct e-commerce storefront for OTC and prescription (medical-authorization-gated) sales with multi-currency checkout across 28 listed countries; federal government procurement via the authorized distributor Integrated Medcraft using assigned National Stock Numbers; regional Military Health System distribution through Panakeia, LLC; and a wholesale/distributor inquiry process for bulk and international orders. Products are ISO 13485 certified, FDA 21 CFR Part 820 compliant, CE marked where applicable, and developed in collaboration with the U.S. Military, with XSTAT field-tested by U.S. Special Operations Forces for over a decade. Revenue, funding totals, and ownership structure beyond the 2013 Saving Lives at Birth Grand Challenge grant (USAID/Gates) and an undisclosed 2014 U.S. Military arrangement are not publicly disclosed; no venture capital or private equity investors are named in the source data.
RevMedx firmographics
Firmographics- Name
- RevMedx
- Legal name
- RevMedx, Inc.
- Website
- https://revmedx.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- RevMedX is a privately held medical device company that designs, develops, and manufactures FDA-cleared expandable minisponge hemorrhage control products (XSTAT, XGAUZE) and CoTCCC-recommended TX Series ratcheting tourniquets for U.S. Military medics, tactical law enforcement, EMS providers, and civilian first responders.
- Ownership category
- akta.pro rank
RevMedx industry classification
Industry- Product category
- Hemorrhage Control Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Surgical Stapling, Suturing & Hemostasis (Staplers, Clips, Sealants, Tourniquets) (HLAHADAL)
- akta.pro secondary industry
- First Aid & Wound Care (Bandages, Dressings, Antiseptics, Burn Care) (CRADAMAB)
Keywords
Where RevMedx is headquartered
LocationHeadquarters
- HQ city
- Wilsonville
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
RevMedx business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations
Revenue model
- Medical Device Product Sales: Direct product sales of hemorrhage control devices including XSTAT injectors, XGAUZE trauma pads, and TX tourniquets through e-commerce, prescription channel, and OTC channel.
- Prescription Device Sales: Sales of FDA-cleared XSTAT P30 and XSTAT P15 through authorized medical professional channels requiring medical license verification and Rx approval.
- Over-the-Counter Products: Direct consumer sales of OTC trauma products including XGAUZE Trauma Pad and TX tourniquets through e-commerce platform.
- Federal Government Procurement: Government sales through authorized distributor Integrated Medcraft for U.S. federal government procurement, including military and emergency services.
- Wholesale and Bulk Distribution: Wholesale and bulk ordering through distributor network, including international distribution opportunities.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | XSTAT P30 - Prescription hemostatic device for junctional wounds |
| One time/ perpetual license | Pay-as-you-go | XSTAT P15 - Prescription hemostatic device for narrow-entrance wounds |
| One time/ perpetual license | Pay-as-you-go | XGAUZE Trauma Pad - OTC expanding sponge dressing |
| One time/ perpetual license | Pay-as-you-go | TX2 Ratcheting Tourniquet - 2-inch width |
| One time/ perpetual license | Pay-as-you-go | TX3 Ratcheting Tourniquet - 3-inch wide band |
| One time/ perpetual license | Pay-as-you-go | TX-XL Extra Large Ratcheting Tourniquet |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels9 records
RevMedx product offering
Product offeringCore offering
RevMedx designs, develops, and manufactures innovative medical devices for prehospital and battlefield hemorrhage control. Its core offerings include the XSTAT line of injectable hemostatic devices that use compressed cellulose minisponges which expand up to 10x on blood contact to stop junctional and extremity bleeding, the XGAUZE expanding sponge trauma dressing, and the TX Series ratcheting tourniquets. Products are FDA-cleared, CoTCCC-recommended, and sold directly to medical professionals, military units, law enforcement, EMS, and civilian consumers.
Product overview
RevMedX is a medical device company focused on hemorrhage control products. The product line consists of two main categories: injectable hemostatic devices (XSTAT® line including P30 and P15) that use expanding minisponge technology for junctional wounds, and TX Series ratcheting tourniquets (TX2, TX3, TX-XL) for limb hemorrhage control. Supporting products include XGAUZE® Trauma Pad, an OTC expanding sponge dressing. All products are designed for military, tactical, and civilian first responder use.
Differentiator
Problem solved
Functional benefit
Brands
- XSTAT: Injectable hemostatic system for severe junctional bleeding using rapidly expanding sponge pouches
- XGAUZE
- TX Series
- AirWrap
Products and services
- XSTAT® P30 FDA-cleared injectable hemostatic device for severe junctional bleeding; uses syringe-style applicator to inject rapidly expanding sponge pouches that absorb blood and expand up to 10x, applying internal pressure to stop bleeding in seconds. Restricted by federal law to sale by or on the order of a physician; priced at $299.00 per single pack.
- XSTAT® P15 FDA-cleared hemostatic device with reduced-diameter applicator optimized for narrow-entrance wounds (e.g., gunshot, shrapnel injuries); delivers one minisponge pouch per applicator for controlled placement. Restricted by federal law to sale by or on the order of a physician; priced at $92.00 per single pack.
- XGAUZE® Trauma Pad Over-the-counter hemostatic dressing using expanding minisponge technology in a compact 4\"x4\" pad; cellulose-based minisponges expand up to 10x on contact with blood; 5-year shelf life; priced at $79.00 per unit.
- TX2 Ratcheting Tourniquet CoTCCC-recommended 2-inch wide ratcheting tourniquet for rapid limb hemorrhage control with self-locking ratchet mechanism, one-handed application, and durable construction for repeated training use; UV-resistant MILSPEC webbing with no expiration date; priced at $39.95 per unit; FSA/HSA eligible.
- TX3 Ratcheting Tourniquet CoTCCC-recommended 3-inch wide ratcheting tourniquet, the widest non-pneumatic tourniquet on the recommended list; designed for prolonged field care with reduced tissue and nerve damage; available in 40\" and 60\" lengths; starting price $35.00 per unit.
- TX-XL Ratcheting Tourniquet Extra large CoTCCC-recommended ratcheting tourniquet for limb hemorrhage control with minimal training; features buckle-and-ratchet system for precise compression under stress or with one hand; priced at $43.50 per unit; FSA/HSA eligible.
Quantifiable outcome
- Minisponges expand up to 10x their compressed size within seconds of blood contact
- +4 more outcomes
Companies that use RevMedx
Customer profileNamed customers6 records
Segments6 records
Ideal customer profiles5 records
RevMedx technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
RevMedx partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- U.S. MilitarycoreRevMedX collaborated with the U.S. military to develop XSTAT devices specifically for battlefield hemorrhage control. The first commercial shipment of XSTAT was made to the U.S. Military in April 2015, marking the first complete production run and global market availability. Products developed with direct input from military medics and first responders.
- Panakeia, LLCcorePanakeia, LLC serves as a distribution partner for RevMedX's AirWrap product, promoting and distributing to the Military Health System. Based in Fayetteville, North Carolina and Stafford, Virginia, Panakeia focuses on healthcare solutions distribution to military medical channels.
- Oregon Health and Science University (OHSU)coreOHSU and RevMedX jointly received a USAID/Gates Foundation seed grant through the Saving Lives at Birth Grand Challenge to develop a novel treatment for postpartum hemorrhage based on RevMedX's XSTAT technology. Selected from over 400 submissions as part of international effort to reduce maternal and neonatal deaths.
- Integrated MedcraftcoreIntegrated Medcraft serves as the authorized distributor for RevMedX products to U.S. federal government customers. Government customers must order through this channel for federal procurement including military and emergency services purchasing.
Scale indicators6 records
Recent moves5 records
Expansion highlights5 records
RevMedx competitors and assessment
Company assessmentBroad incumbents
- Stryker: Stryker is a diversified medical device giant with relevant hemorrhage control and emergency/trauma products, including hemostatic agents and surgical supplies. Competes indirectly as a broad incumbent with greater R&D resources and distribution scale.
- Becton Dickinson (BD): BD is a global medical technology incumbent with extensive surgical hemostasis and wound care portfolios. While not solely focused on tactical hemorrhage control, BD's scale and government sales infrastructure make it a competitor for hospital and large-system contracts.
- Teleflex: Teleflex is a large medical device incumbent that markets tactical/EMS hemorrhage control products including hemostatic dressings and tourniquets. Sells to military, EMS, and hospital channels with a broader product portfolio than RevMedX.
Direct peers
- Z-Medica (QuikClot): Z-Medica is a direct competitor in hemostatic dressings and gauzes, selling the widely adopted QuikClot combat gauze line to military and civilian first responders. Operates in the same hemorrhage control category with overlapping customer base in tactical and EMS markets.
- Celox Medical: Celox manufactures chitosan-based hemostatic gauze and granules marketed for military and civilian trauma care, directly competing with XSTAT and XGAUZE. Holds CE Mark and FDA clearances and is sold through U.S. and NATO military channels.
- North American Rescue: North American Rescue is a leading supplier of tactical combat casualty care and EMS products including hemostatic dressings and tourniquets, with deep military procurement relationships similar to RevMedX. Competes head-to-head in federal supply chain and civilian first-responder kits.
- Combat Medical Systems: Combat Medical Systems designs and distributes tactical combat casualty care products including hemostatic dressings and tourniquets. Directly comparable niche medical device player serving military, law enforcement, and EMS customers.
- Tricol Biomedical: Tricol Biomedical manufactures the HemCon chitosan-based hemostatic bandages used in military and civilian trauma kits. Competes directly with XGAUZE in the OTC and tactical hemostatic dressing segment.
- SAM Medical Products: SAM Medical Products manufactures the widely adopted SAM XT tourniquet and related trauma medical devices. Directly comparable in tourniquet product category and shares the tactical/EMS/military customer base with RevMedX's TX Series.
Emerging players
- Mercer Group (CRD): Mercer Medical and similar emerging tactical/EMS medical device firms develop hemostatic and trauma products for civilian and military markets, representing a class of smaller competitors in adjacent wound care categories.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
RevMedx social profiles
Digital presenceRevMedx compliance and trust
Trust signalCompliance3 records
RevMedx financial estimates
Financial estimateRevenue estimate
Valuation estimate
RevMedx leadership team
Management profileNumber of profiles
Profiles4 records
RevMedx funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
RevMedx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about RevMedx
What does RevMedx do?
RevMedx designs, develops, and manufactures innovative medical devices for prehospital and battlefield hemorrhage control. Its core offerings include the XSTAT line of injectable hemostatic devices that use compressed cellulose minisponges which expand up to 10x on blood contact to stop junctional and extremity bleeding, the XGAUZE expanding sponge trauma dressing, and the TX Series ratcheting tourniquets. Products are FDA-cleared, CoTCCC-recommended, and sold directly to medical professionals, military units, law enforcement, EMS, and civilian consumers.
Is RevMedx a public or private company?
RevMedx is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was RevMedx founded?
RevMedx was founded in 2013. It employs 11 to 50 people.
Where is RevMedx based?
RevMedx is headquartered in Wilsonville, United States, in the North America region.
How does RevMedx make money?
Five revenue lines are on record. Medical Device Product Sales are the primary driver. The others are prescription Device Sales, over-the-Counter Products, federal Government Procurement and wholesale and Bulk Distribution.
Who are RevMedx's main competitors?
Broad incumbents on record are Stryker, Becton Dickinson (BD) and Teleflex. Direct peers are Z-Medica (QuikClot), Celox Medical, North American Rescue, Combat Medical Systems, Tricol Biomedical and SAM Medical Products. Mercer Group (CRD) is listed as an emerging player.
Does RevMedx have an API?
No public API is recorded for RevMedx.
What industry is RevMedx in?
RevMedx's product category is Hemorrhage Control Medical Devices. Its primary akta.pro industry code is HLAHADAL, Surgical Stapling, Suturing & Hemostasis (Staplers, Clips, Sealants, Tourniquets), with a secondary code of CRADAMAB, First Aid & Wound Care (Bandages, Dressings, Antiseptics, Burn Care). Its NAICS code is 339112 and its SIC code is 3841.